Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:24 PM
Ignite Modification Date:
2025-12-26 @ 5:24 PM
NCT ID:
NCT03487406
Eligibility Criteria:
Inclusion Criteria:
* Abnormal spirometry with FEV1\<80% and FEV1/FVC ratio \<70% of predicted
* Smoking history that is 10-pack years or greater (current or ex smokers can be included)
* Have capacity to consent
Exclusion Criteria:
* Any condition that is being concurrently treated through anticoagulation or antiplatelet therapy including Aspirin (any form of Aspirin) or Ticagrelor (atrial fibrillation, deep vein thrombosis, valve prosthesis, recent myocardial infarction, use of drug eluting stents)
* Other specific contraindications to management with antiplatelet medication (bleeding risks, allergies)
* Any contraindication for Aspirin and Ticagrelor use
* Other concurrent terminal illnesses with life expectancy less than 1 year (congestive cardiac failure, carcinoma etc)
* Current involvement in another clinical trial or exposure to another IMP within the previous 30 days
* COPD with an atypical cause (e.g. A1- antitrypsin deficiency)
* Patients who are unable to provide informed consent
* Planned/ Expected major surgery where anti-platelet therapy would be ceased
* Pregnancy, planned pregnancy or current breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03487406
Study Brief:
Protocol Section:
NCT03487406